Molecular and Cellular Mechanism of Okadaic Acid (OKA)-Induced Neurotoxicity: A Novel Tool for Alzheimer’s Disease Therapeutic Application

Molecular Neurobiology

Volumn 50, Issue 3, 2014, Pages 852-865

  Kamat, Pradip K ^a   Rai, Shivika ^b   Swarnkar, Supriya ^c   Shukla, Rakesh ^b   Nath, Chandishwar ^b  

^a University of Louisville School of Medicine   (United States)

^b CENTRAL DRUG RESEARCH INSTITUTE   (India)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Alzheimer s disease; Kinases; Neurotoxicity; Okadaic acid

Indexed keywords

NEUROTOXIN; OKADAIC ACID;

ALZHEIMER DISEASE; ANIMAL; DRUG EFFECTS; HUMAN; NERVE CELL; PATHOLOGY; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ALZHEIMER DISEASE; ANIMALS; HUMANS; NEURONS; NEUROTOXINS; OKADAIC ACID; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 84897358323     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-014-8699-4     Document Type: Review

References (145)

1. Cohen P, Holmes CF, Tsukitani Y (1990) Okadaic acid: a new probe for the study of cellular regulation. Trends Biochem Sci 15(3):98–102
2. Kim D, Su J, Cotman CW (1999) Sequence of neurodegeneration and accumulation of phosphorylated tau in cultured neurons after okadaic acid treatment. Brain Res 839(2):253–262
3. Malchiodi-Albedi F, Petrucci TC, Picconi B, Iosi F, Falchi M (1997) Protein phosphatase inhibitors induce modification of synapse structure and tau hyperphosphorylation in cultured rat hippocampal neurons. J Neurosci Res 48(5):425–438
4. Wang J, Tung YC, Wang Y, Li XT, Iqbal K, Grundke-Iqbal I (2001) Hyperphosphorylation and accumulation of neurofilament proteins in Alzheimer disease brain and in okadaic acid-treated SY5Y cells. FEBS Lett 507(1):81–87
5. Kamat PK, Tota S, Shukla R, Ali S, Najmi AK and Nath C Mitochondrial dysfunction: a crucial event in okadaic acid (ICV) induced memory impairment and apoptotic cell death in rat brain. Pharmacol Biochem Behav 100(2):311–319
6. He J, Yamada K, Zou LB, Nabeshima T (2001) Spatial memory deficit and neurodegeneration induced by the direct injection of okadaic acid into the hippocampus in rats. J Neural Transm 108(12):1435–1443
7. Arias C, Becerra-Garcia F, Arrieta I, Tapia R (1998) The protein phosphatase inhibitor okadaic acid induces heat shock protein expression and neurodegeneration in rat hippocampus in vivo. Exp Neurol 153(2):242–254
8. Lee J, Hong H, Im J, Byun H, Kim D (2000) The formation of PHF-1 and SMI-31 positive dystrophic neurites in rat hippocampus following acute injection of okadaic acid. Neurosci Lett 282(1–2):49–52
9. Sun L, Liu SY, Zhou XW, Wang XC, Liu R, Wang Q, Wang JZ (2003) Inhibition of protein phosphatase 2A- and protein phosphatase 1-induced tau hyperphosphorylation and impairment of spatial memory retention in rats. Neuroscience 118(4):1175–1182
10. Kamat PK, Tota S, Saxena G, Shukla R and Nath C Okadaic acid (ICV) induced memory impairment in rats: a suitable experimental model to test anti-dementia activity. Brain Res 1309:66–74.
11. Yoon SY, Choi JE, Yoon JH, Huh JW, Kim DH (2006) BACE inhibitor reduces APP-beta-C-terminal fragment accumulation in axonal swellings of okadaic acid-induced neurodegeneration. Neurobiol Dis 22(2):435–444
12. Kamat PK, Tota S, Rai S, Shukla R, Ali S, Najmi AK and Nath C Okadaic acid induced neurotoxicity leads to central cholinergic dysfunction in rats. Eur J Pharmacol 690(1–3):90–98.
13. Kamat PK, Tota S, Rai S, Swarnkar S, Shukla R and Nath C A study on neuroinflammatory marker in brain areas of okadaic acid (ICV) induced memory impaired rats. Life Sci 90(19–20):713–720.
14. Kamat PK, Rai S and Nath C Okadaic acid induced neurotoxicity: an emerging tool to study Alzheimer’s disease pathology. Neurotoxicology 37:163–172.
15. Kamat PK, Rai S, Swarnkar S, Shukla R, Ali S, Najmi AK and Nath C Okadaic acid-induced Tau phosphorylation in rat brain: role of NMDA receptor. Neuroscience 238:97–113.
16. Duan DX, Chai GS, Ni ZF, Hu Y, Luo Y, Cheng XS, Chen NN, Wang JZ and Liu GP Phosphorylation of tau by death-associated protein kinase 1 antagonizes the kinase-induced cell apoptosis. J Alzheimers Dis 37(4):795–808.
17. Li X, Uemura K, Hashimoto T, Nasser-Ghodsi N, Arimon M, Lill CM, Palazzolo I, Krainc D, Hyman BT and Berezovska O Neuronal activity and secreted amyloid beta lead to altered amyloid beta precursor protein and presenilin 1 interactions. Neurobiol Dis 50:127–134.
18. Murray PS, Kirkwood CM, Gray MC, Fish KN, Ikonomovic MD, Hamilton RL, Kofler JK, Klunk WE, Lopez OL and Sweet RA Hyperphosphorylated tau is elevated in Alzheimer’s disease with psychosis. J Alzheimers Dis.
19. Polydoro M, Dzhala VI, Pooler AM, Nicholls SB, McKinney AP, Sanchez L, Pitstick R, Carlson GA, Staley KJ, Spires-Jones TL and Hyman BT Soluble pathological tau in the entorhinal cortex leads to presynaptic deficits in an early Alzheimer’s disease model. Acta Neuropathol.
20. Salcedo-Tello P, Hernandez-Ortega K and Arias C Susceptibility to GSK3beta-induced tau phosphorylation differs between the young and aged hippocampus after Wnt signaling inhibition. J Alzheimers Dis.
21. Avruch J, Khokhlatchev A, Kyriakis JM, Luo Z, Tzivion G, Vavvas D, Zhang XF (2001) Ras activation of the Raf kinase: tyrosine kinase recruitment of the MAP kinase cascade. Recent Prog Horm Res 56:127–155
22. Sweatt JD (2001) The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory. J Neurochem 76(1):1–10
23. Sharma SK, Carew TJ (2004) The roles of MAPK cascades in synaptic plasticity and memory in Aplysia: facilitatory effects and inhibitory constraints. Learn Mem 11(4):373–378
24. Toyoda H, Zhao MG, Xu H, Wu LJ, Ren M, Zhuo M (2007) Requirement of extracellular signal-regulated kinase/mitogen-activated protein kinase for long-term potentiation in adult mouse anterior cingulate cortex. Mol Pain 3:36
25. Hanyu Y, Imai KK, Kawasaki Y, Nakamura T, Nakaseko Y, Nagao K, Kokubu A, Ebe M, Fujisawa A, Hayashi T, Obuse C, Yanagida M (2009) Schizosaccharomyces pombe cell division cycle under limited glucose requires Ssp1 kinase, the putative CaMKK, and Sds23, a PP2A-related phosphatase inhibitor. Genes Cells 14(5):539–554
26. Sereno L, Coma M, Rodriguez M, Sanchez-Ferrer P, Sanchez MB, Gich I, Agullo JM, Perez M, Avila J, Guardia-Laguarta C, Clarimon J, Lleo A, Gomez-Isla T (2009) A novel GSK-3beta inhibitor reduces Alzheimer’s pathology and rescues neuronal loss in vivo. Neurobiol Dis 35(3):359–367
27. Dickey AS and Strack S PKA/AKAP1 and PP2A/Bbeta2 regulate neuronal morphogenesis via Drp1 phosphorylation and mitochondrial bioenergetics. J Neurosci 31(44):15716–15726.
28. Jeong W, Kim J, Ahn SE, Lee SI, Bazer FW, Han JY and Song G AHCYL1 is mediated by estrogen-induced ERK1/2 MAPK cell signaling and microRNA regulation to effect functional aspects of the avian oviduct. PLoS One 7(11):e49204.
29. Alonso A, Zaidi T, Novak M, Grundke-Iqbal I, Iqbal K (2001) Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments. Proc Natl Acad Sci U S A 98(12):6923–6928
30. Sato S, Tatebayashi Y, Akagi T, Chui DH, Murayama M, Miyasaka T, Planel E, Tanemura K, Sun X, Hashikawa T, Yoshioka K, Ishiguro K, Takashima A (2002) Aberrant tau phosphorylation by glycogen synthase kinase-3beta and JNK3 induces oligomeric tau fibrils in COS-7 cells. J Biol Chem 277(44):42060–42065
31. Gong CX, Liu F, Grundke-Iqbal I, Iqbal K (2005) Post-translational modifications of tau protein in Alzheimer’s disease. J Neural Transm 112(6):813–838
32. Lucas JJ, Hernandez F, Gomez-Ramos P, Moran MA, Hen R, Avila J (2001) Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice. EMBO J 20(1–2):27–39
33. Fath T, Eidenmuller J, Brandt R (2002) Tau-mediated cytotoxicity in a pseudohyperphosphorylation model of Alzheimer’s disease. J Neurosci 22(22):9733–9741
34. Jackson GR, Wiedau-Pazos M, Sang TK, Wagle N, Brown CA, Massachi S, Geschwind DH (2002) Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila. Neuron 34(4):509–519
35. Perez M, Hernandez F, Gomez-Ramos A, Smith M, Perry G, Avila J (2002) Formation of aberrant phosphotau fibrillar polymers in neural cultured cells. Eur J Biochem 269(5):1484–1489
36. Lu Y, He HJ, Zhou J, Miao JY, Lu J, He YG, Pan R, Wei Y, Liu Y and He RQ Hyperphosphorylation results in tau dysfunction in DNA folding and protection. J Alzheimers Dis 37(3):551–563.
37. Sontag E, Luangpirom A, Hladik C, Mudrak I, Ogris E, Speciale S, White CL 3rd (2004) Altered expression levels of the protein phosphatase 2A ABalphaC enzyme are associated with Alzheimer disease pathology. J Neuropathol Exp Neurol 63(4):287–301
38. Sugiyama N, Konoki K, Tachibana K (2007) Isolation and characterization of okadaic acid binding proteins from the marine sponge Halichondria okadai. Biochemistry 46(40):11410–11420
39. Kins S, Kurosinski P, Nitsch RM, Gotz J (2003) Activation of the ERK and JNK signaling pathways caused by neuron-specific inhibition of PP2A in transgenic mice. Am J Pathol 163(3):833–843
40. Honkanen RE, Zwiller J, Daily SL, Khatra BS, Dukelow M, Boynton AL (1991) Identification, purification, and characterization of a novel serine/threonine protein phosphatase from bovine brain. J Biol Chem 266(10):6614–6619
41. Brewis ND, Street AJ, Prescott AR, Cohen PT (1993) PPX, a novel protein serine/threonine phosphatase localized to centrosomes. EMBO J 12(3):987–996
42. Chen MX, McPartlin AE, Brown L, Chen YH, Barker HM, Cohen PT (1994) A novel human protein serine/threonine phosphatase, which possesses four tetratricopeptide repeat motifs and localizes to the nucleus. EMBO J 13(18):4278–4290
43. Fernandez MT, Zitko V, Gascon S, Novelli A (1991) The marine toxin okadaic acid is a potent neurotoxin for cultured cerebellar neurons. Life Sci 49(19):PL157–PL162
44. Sassa T, Richter WW, Uda N, Suganuma M, Suguri H, Yoshizawa S, Hirota M, Fujiki H (1989) Apparent “activation” of protein kinases by okadaic acid class tumor promoters. Biochem Biophys Res Commun 159(3):939–944
45. Haystead TA, Sim AT, Carling D, Honnor RC, Tsukitani Y, Cohen P, Hardie DG (1989) Effects of the tumour promoter okadaic acid on intracellular protein phosphorylation and metabolism. Nature 337(6202):78–81
46. Pei JJ, Braak H, An WL, Winblad B, Cowburn RF, Iqbal K, Grundke-Iqbal I (2002) Up-regulation of mitogen-activated protein kinases ERK1/2 and MEK1/2 is associated with the progression of neurofibrillary degeneration in Alzheimer’s disease. Brain Res Mol Brain Res 109(1–2):45–55
47. Ferrer I, Blanco R (2000) N-myc and c-myc expression in Alzheimer disease, Huntington disease and Parkinson disease. Brain Res Mol Brain Res 77(2):270–276
48. Pei JJ, Braak E, Braak H, Grundke-Iqbal I, Iqbal K, Winblad B, Cowburn RF (2001) Localization of active forms of C-jun kinase (JNK) and p38 kinase in Alzheimer’s disease brains at different stages of neurofibrillary degeneration. J Alzheimers Dis 3(1):41–48
49. Gong CX, Lidsky T, Wegiel J, Zuck L, Grundke-Iqbal I, Iqbal K (2000) Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain. Implications for neurofibrillary degeneration in Alzheimer’s disease. J Biol Chem 275(8):5535–5544
50. Zhu Y, Qin L, Yoshida T, Inouye M (2000) Phosphatase activity of histidine kinase EnvZ without kinase catalytic domain. Proc Natl Acad Sci U S A 97(14):7808–7813
51. Iqbal K, Alonso AD, Gondal JA, Gong CX, Haque N, Khatoon S, Sengupta A, Wang JZ, Grundke-Iqbal I (2000) Mechanism of neurofibrillary degeneration and pharmacologic therapeutic approach. J Neural Transm Suppl 59:213–222
52. Zhang Y, Zhong S, Dong Z, Chen N, Bode AM, Ma W, Dong Z (2001) UVA induces Ser381 phosphorylation of p90RSK/MAPKAP-K1 via ERK and JNK pathways. J Biol Chem 276(18):14572–14580
53. Zhang BH, Guan KL (2001) Regulation of the Raf kinase by phosphorylation. Exp Lung Res 27(3):269–295
54. Roder HM, Eden PA, Ingram VM (1993) Brain protein kinase PK40erk converts TAU into a PHF-like form as found in Alzheimer’s disease. Biochem Biophys Res Commun 193(2):639–647
55. Pei JJ, Braak H, An WL, Winblad B, Cowburn RF, Iqbal K, Grundke-Iqbal I (2002) Up-regulation of mitogen-activated protein kinases ERK1/2 and MEK1/2 is associated with the progression of neurofibrillary degeneration in Alzheimer’s disease. Brain Res Mol Brain Res 109(1–2):45–55
56. Ferrer I, Blanco R, Carmona M, Puig B (2001) Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies. J Neural Transm 108(12):1397–1415
57. Ferrer I, Blanco R, Carmona M, Puig B, Barrachina M, Gomez C, Ambrosio S (2001) Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson’s disease and dementia with Lewy bodies. J Neural Transm 108(12):1383–1396
58. Pei JJ, Braak E, Braak H, Grundke-Iqbal I, Iqbal K, Winblad B, Cowburn RF (2001) Localization of active forms of C-jun kinase (JNK) and p38 kinase in Alzheimer’s disease brains at different stages of neurofibrillary degeneration. J Alzheimers Dis 3(1):41–48
59. Zhu X, Rottkamp CA, Boux H, Takeda A, Perry G, Smith MA (2000) Activation of p38 kinase links tau phosphorylation, oxidative stress, and cell cycle-related events in Alzheimer disease. J Neuropathol Exp Neurol 59(10):880–888
60. Bennecib M, Gong CX, Grundke-Iqbal I, Iqbal K (2001) Inhibition of PP-2A upregulates CaMKII in rat forebrain and induces hyperphosphorylation of tau at Ser 262/356. FEBS Lett 490(1–2):15–22
61. Pei JJ, Sersen E, Iqbal K, Grundke-Iqbal I (1994) Expression of protein phosphatases (PP-1, PP-2A, PP-2B and PTP-1B) and protein kinases (MAP kinase and P34cdc2) in the hippocampus of patients with Alzheimer disease and normal aged individuals. Brain Res 655(1–2):70–76
62. Gong CX, Wegiel J, Lidsky T, Zuck L, Avila J, Wisniewski HM, Grundke-Iqbal I, Iqbal K (2000) Regulation of phosphorylation of neuronal microtubule-associated proteins MAP1b and MAP2 by protein phosphatase-2A and -2B in rat brain. Brain Res 853(2):299–309
63. Bennecib M, Gong CX, Grundke-Iqbal I, Iqbal K (2000) Role of protein phosphatase-2A and -1 in the regulation of GSK-3, cdk5 and cdc2 and the phosphorylation of tau in rat forebrain. FEBS Lett 485(1):87–93
64. Vogelsberg-Ragaglia V, Schuck T, Trojanowski JQ, Lee VM (2001) PP2A mRNA expression is quantitatively decreased in Alzheimer’s disease hippocampus. Exp Neurol 168(2):402–412
65. Iqbal K, Alonso A, Gong C, Khatoon S, Kudo T, Singh T, Grundke-Iqbal I (1993) Molecular pathology of Alzheimer neurofibrillary degeneration. Acta Neurobiol Exp (Wars) 53(1):325–335
66. Parameswaran N, Nambi P, Hall CS, Brooks DP, Spielman WS (2000) Adrenomedullin decreases extracellular signal-regulated kinase activity through an increase in protein phosphatase-2A activity in mesangial cells. Eur J Pharmacol 388(2):133–138
67. Pei JJ, Gong CX, An WL, Winblad B, Cowburn RF, Grundke-Iqbal I, Iqbal K (2003) Okadaic-acid-induced inhibition of protein phosphatase 2A produces activation of mitogen-activated protein kinases ERK1/2, MEK1/2, and p70 S6, similar to that in Alzheimer’s disease. Am J Pathol 163(3):845–858
68. Kockx M, Guo DL, Traini M, Gaus K, Kay J, Wimmer-Kleikamp S, Rentero C, Burnett JR, Le Goff W, Van Eck M, Stow JL, Jessup W, Kritharides L (2009) Cyclosporin A decreases apolipoprotein E secretion from human macrophages via a protein phosphatase 2B-dependent and ATP-binding cassette transporter A1 (ABCA1)-independent pathway. J Biol Chem 284(36):24144–24154
69. Chang HT, Cortez S, Vonsattel JP, Stopa EG, Schelper RL (2004) Familial frontotemporal dementia: a report of three cases of severe cerebral atrophy with rare inclusions that are negative for tau and synuclein, but positive for ubiquitin. Acta Neuropathol 108(1):10–16
70. Zhang Y, Dong Z, Nomura M, Zhong S, Chen N, Bode AM, Dong Z (2001) Signal transduction pathways involved in phosphorylation and activation of p70S6K following exposure to UVA irradiation. J Biol Chem 276(24):20913–20923
71. Parameswaran N, Nambi P, Hall CS, Brooks DP, Spielman WS (2000) Adrenomedullin decreases extracellular signal-regulated kinase activity through an increase in protein phosphatase-2A activity in mesangial cells. Eur J Pharmacol 388(2):133–138
72. Adachi M, Fukuda M, Nishida E (2000) Nuclear export of MAP kinase (ERK) involves a MAP kinase kinase (MEK)-dependent active transport mechanism. J Cell Biol 148(5):849–856
73. Christopher DA, Li X, Kim M, Mullet JE (1997) Involvement of protein kinase and extraplastidic serine/threonine protein phosphatases in signaling pathways regulating plastid transcription and the psbD blue light-responsive promoter in barley. Plant Physiol 113(4):1273–1282
74. Davis RJ (2000) Signal transduction by the JNK group of MAP kinases. Cell 103(2):239–252
75. Szegezdi E, Logue SE, Gorman AM, Samali A (2006) Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Rep 7(9):880–885
76. Gao JX, Zhou YQ, Zhang RH, Ma XL, Liu KJ (2005) Caspase-3 plays a required role in PC12 cell apoptotic death induced by roscovitine. Sheng Li Xue Bao 57(6):755–760
77. Ravindran J, Gupta N, Agrawal M, Bala Bhaskar AS and Lakshmana Rao PV Modulation of ROS/MAPK signaling pathways by okadaic acid leads to cell death via, mitochondrial mediated caspase-dependent mechanism. Apoptosis 16(2):145–161.
78. Avila J, Leon-Espinosa G, Garcia E, Garcia-Escudero V, Hernandez F and Defelipe J Tau phosphorylation by GSK3 in different conditions. Int J Alzheimers Dis 2012:578373.
79. Gong CX, Wang JZ, Iqbal K, Grundke-Iqbal I (2003) Inhibition of protein phosphatase 2A induces phosphorylation and accumulation of neurofilaments in metabolically active rat brain slices. Neurosci Lett 340(2):107–110
80. Kimura T, Yamashita S, Nakao S, Park JM, Murayama M, Mizoroki T, Yoshiike Y, Sahara N, Takashima A (2008) GSK-3beta is required for memory reconsolidation in adult brain. PLoS One 3(10):e3540
81. Martin L, Page G and Terro F Tau phosphorylation and neuronal apoptosis induced by the blockade of PP2A preferentially involve GSK3beta. Neurochem Int 59(2):235–250.
82. Takashima A (2006) GSK-3 is essential in the pathogenesis of Alzheimer’s disease. J Alzheimers Dis 9(3 Suppl):309–317
83. Leroy K, Yilmaz Z, Brion JP (2007) Increased level of active GSK-3beta in Alzheimer’s disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration. Neuropathol Appl Neurobiol 33(1):43–55
84. Ballou LM, Tian PY, Lin HY, Jiang YP, Lin RZ (2001) Dual regulation of glycogen synthase kinase-3beta by the alpha1A-adrenergic receptor. J Biol Chem 276(44):40910–40916
85. Jackson GR, Wiedau-Pazos M, Sang TK, Wagle N, Brown CA, Massachi S, Geschwind DH (2002) Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila. Neuron 34(4):509–519
86. Engel T, Hernandez F, Avila J, Lucas JJ (2006) Full reversal of Alzheimer’s disease-like phenotype in a mouse model with conditional overexpression of glycogen synthase kinase-3. J Neurosci 26(19):5083–5090
87. Wittmann CW, Wszolek MF, Shulman JM, Salvaterra PM, Lewis J, Hutton M, Feany MB (2001) Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles. Science 293(5530):711–714
88. Lee VM, Goedert M, Trojanowski JQ (2001) Neurodegenerative tauopathies. Annu Rev Neurosci 24:1121–1159
89. Noble W, Planel E, Zehr C, Olm V, Meyerson J, Suleman F, Gaynor K, Wang L, LaFrancois J, Feinstein B, Burns M, Krishnamurthy P, Wen Y, Bhat R, Lewis J, Dickson D, Duff K (2005) Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo. Proc Natl Acad Sci U S A 102(19):6990–6995
90. Balaraman Y, Limaye AR, Levey AI, Srinivasan S (2006) Glycogen synthase kinase 3beta and Alzheimer’s disease: pathophysiological and therapeutic significance. Cell Mol Life Sci 63(11):1226–1235
91. 2+/calmodulin-dependent protein kinase II as demonstrated tandem mass spectrometry. Neurosci Lett 353(3):185–188
92. 2+/calmodulin-dependent protein kinase II: the role of structure and autoregulation in cellular function. Annu Rev Biochem 71:473–510
93. 2+/calmodulin-dependent protein kinase II—discovery, progress in a quarter of a century, and perspective: implication for learning and memory. Biol Pharm Bull 28(8):1342–1354
94. 2+/calmodulin-dependent protein kinases. J Biochem 129(2):193–199
95. 2+/calmodulin-dependent protein kinase II. J Biol Chem 276(6):3719–3722
96. Chang BH, Mukherji S, Soderling TR (2001) Calcium/calmodulin-dependent protein kinase II inhibitor protein: localization of isoforms in rat brain. Neuroscience 102(4):767–777
97. 2+)/CaM-dependent kinases: from activation to function. Annu Rev Pharmacol Toxicol 41:471–505
98. Brindle PK, Montminy MR (1992) The CREB family of transcription activators. Curr Opin Genet Dev 2(2):199–204
99. Garg S, Timm T, Mandelkow EM, Mandelkow E and Wang Y Cleavage of Tau by calpain in Alzheimer’s disease: the quest for the toxic 17 kD fragment. Neurobiol Aging 32(1):1–14.
100. Nixon RA (2003) The calpains in aging and aging-related diseases. Ageing Res Rev 2(4):407–418
101. Yamashima T Reconsider Alzheimer’s disease by the ‘calpain–cathepsin hypothesis’—a perspective review. Prog Neurobiol 105:1–23.
102. Liu J, Liu MC, Wang KK (2008) Physiological and pathological actions of calpains in glutamatergic neurons. Sci Signal 1(23):tr3
103. Liu J, Liu MC, Wang KK (2008) Calpain in the CNS: from synaptic function to neurotoxicity. Sci Signal 1(14):re1
104. Yamauchi M, Yamaguchi T, Kaji H, Sugimoto T, Chihara K (2005) Involvement of calcium-sensing receptor in osteoblastic differentiation of mouse MC3T3-E1 cells. Am J Physiol Endocrinol Metab 288(3):E608–E616
105. Trinchese F, Fa M, Liu S, Zhang H, Hidalgo A, Schmidt SD, Yamaguchi H, Yoshii N, Mathews PM, Nixon RA, Arancio O (2008) Inhibition of calpains improves memory and synaptic transmission in a mouse model of Alzheimer disease. J Clin Invest 118(8):2796–2807
106. Mattson MP, Chan SL (2001) Dysregulation of cellular calcium homeostasis in Alzheimer’s disease: bad genes and bad habits. J Mol Neurosci 17(2):205–224
107. Sultana R, Boyd-Kimball D, Poon HF, Cai J, Pierce WM, Klein JB, Merchant M, Markesbery WR, Butterfield DA (2006) Redox proteomics identification of oxidized proteins in Alzheimer’s disease hippocampus and cerebellum: an approach to understand pathological and biochemical alterations in AD. Neurobiol Aging 27(11):1564–1576
108. Butterfield DA, Poon HF, St Clair D, Keller JN, Pierce WM, Klein JB, Markesbery WR (2006) Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer’s disease. Neurobiol Dis 22(2):223–232
109. Sontag E, Hladik C, Montgomery L, Luangpirom A, Mudrak I, Ogris E, White CL 3rd (2004) Downregulation of protein phosphatase 2A carboxyl methylation and methyltransferase may contribute to Alzheimer disease pathogenesis. J Neuropathol Exp Neurol 63(10):1080–1091
110. Celsi F, Svedberg M, Unger C, Cotman CW, Carri MT, Ottersen OP, Nordberg A, Torp R (2007) Beta-amyloid causes downregulation of calcineurin in neurons through induction of oxidative stress. Neurobiol Dis 26(2):342–352
111. Yi KD, Covey DF, Simpkins JW (2009) Mechanism of okadaic acid-induced neuronal death and the effect of estrogens. J Neurochem 108(3):732–740
112. Rahman A, Grundke-Iqbal I, Iqbal K (2005) Phosphothreonine-212 of Alzheimer abnormally hyperphosphorylated tau is a preferred substrate of protein phosphatase-1. Neurochem Res 30(2):277–287
113. Poppek D, Keck S, Ermak G, Jung T, Stolzing A, Ullrich O, Davies KJ, Grune T (2006) Phosphorylation inhibits turnover of the tau protein by the proteasome: influence of RCAN1 and oxidative stress. Biochem J 400(3):511–520
114. Ho Y, Logue E, Callaway CW, DeFranco DB (2007) Different mechanisms account for extracellular-signal regulated kinase activation in distinct brain regions following global ischemia and reperfusion. Neuroscience 145(1):248–255
115. Cargnello M and Roux PP Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol Mol Biol Rev 75(1):50–83.
116. Ray RM, Bhattacharya S, Johnson LR (2005) Protein phosphatase 2A regulates apoptosis in intestinal epithelial cells. J Biol Chem 280(35):31091–31100
117. Garcia A, Cayla X, Caudron B, Deveaud E, Roncal F, Rebollo A (2004) New insights in protein phosphorylation: a signature for protein phosphatase 1 interacting proteins. CR Biol 327(2):93–97
118. Yoon S, Choi J, Yoon J, Huh JW, Kim D (2006) Okadaic acid induces JNK activation, bim overexpression and mitochondrial dysfunction in cultured rat cortical neurons. Neurosci Lett 394(3):190–195
119. Kraft CA, Efimova T, Eckert RL (2007) Activation of PKCdelta and p38delta MAPK during okadaic acid dependent keratinocyte apoptosis. Arch Dermatol Res 299(2):71–83
120. Rice AB, Ingram JL, Bonner JC (2002) p38 mitogen-activated protein kinase regulates growth factor-induced mitogenesis of rat pulmonary myofibroblasts. Am J Respir Cell Mol Biol 27(6):759–765
121. Wang Z, Yang H, Tachado SD, Capo-Aponte JE, Bildin VN, Koziel H, Reinach PS (2006) Phosphatase-mediated crosstalk control of ERK and p38 MAPK signaling in corneal epithelial cells. Invest Ophthalmol Vis Sci 47(12):5267–5275
122. Schonwasser DC, Marais RM, Marshall CJ, Parker PJ (1998) Activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by conventional, novel, and atypical protein kinase C isotypes. Mol Cell Biol 18(2):790–798
123. Hu JY, Chen Y, Schacher S (2007) Multifunctional role of protein kinase C in regulating the formation and maturation of specific synapses. J Neurosci 27(43):11712–11724
124. Yi KD, Covey DF, Simpkins JW (2009) Mechanism of okadaic acid-induced neuronal death and the effect of estrogens. J Neurochem 108(3):732–740
125. Yi KD, Chung J, Pang P, Simpkins JW (2005) Role of protein phosphatases in estrogen-mediated neuroprotection. J Neurosci 25(31):7191–7198
126. Yi KD, Simpkins JW (2008) Protein phosphatase 1, protein phosphatase 2A, and calcineurin play a role in estrogen-mediated neuroprotection. Endocrinology 149(10):5235–5243
127. Yi KD, Cai ZY, Covey DF, Simpkins JW (2008) Estrogen receptor-independent neuroprotection via protein phosphatase preservation and attenuation of persistent extracellular signal-regulated kinase 1/2 activation. J Pharmacol Exp Ther 324(3):1188–1195
128. Tunez I, Collado JA, Medina FJ, Munoz MC, Gordillo R, Sampedro C, Moyano MJ, Feijoo M, Muntane J, Montilla P (2006) Protective effect of carvedilol on oxidative stress induced by okadaic acid in N1E-115 cells. Pharmacol Res 54(3):241–246
129. Yin YY, Liu H, Cong XB, Liu Z, Wang Q, Wang JZ, Zhu LQ (2010) Acetyl-l-carnitine attenuates okadaic acid induced tau hyperphosphorylation and spatial memory impairment in rats. J Alzheimers Dis 19(2):735–746
130. Dwivedi, S., Nagarajan, R., Hanif, K., Siddiqui, H. H., Nath, C., & Shukla, R. (2013). Standardized extract of Bacopa monniera attenuates okadaic acid induced memory dysfunction in rats: effect on Nrf2 pathway. Evid Based Complement Alternat Med, 294501.
131. Rajasekar N, Dwivedi S, Tota SK, Kamat PK, Hanif K, Nath C, Shukla R (2013) Neuroprotective effect of curcumin on okadaic acid induced memory impairment in mice. Eur J Pharmacol 715(1–3):381–394
132. Tunez I, Collado JA, Medina FJ, Munoz MC, Gordillo R, Sampedro C, Moyano MJ, Feijoo M, Muntane J, Montilla P (2006) Protective effect of carvedilol on oxidative stress induced by okadaic acid in N1E-115 cells. Pharmacol Res 54(3):241–246
133. Wang YP, Li XT, Liu SJ, Zhou XW, Wang XC, Wang JZ (2004) Melatonin ameliorated okadaic-acid induced Alzheimer-like lesions. Acta Pharmacol Sin 25(3):276–280
134. Montilla-Lopez P, Munoz-Agueda MC, Feijoo Lopez M, Munoz-Castaneda JR, Bujalance-Arenas I, Tunez-Finana I (2002) Comparison of melatonin versus vitamin C on oxidative stress and antioxidant enzyme activity in Alzheimer’s disease induced by okadaic acid in neuroblastoma cells. Eur J Pharmacol 451(3):237–243
135. Li H, Wu X, Wu Q, Gong D, Shi M, Guan L, Zhang J, Liu J, Yuan B, Han G, Zou Y (2014) Green tea polyphenols protect against okadaic acid-induced acute learning and memory impairments in rats. Nutrition 30(3):337–342
136. Song, X. Y., Hu, J. F., Chu, S. F., Zhang, Z., Xu, S., Yuan, Y. H., Han, N., Liu, Y., Niu, F., He, X., & Chen, N. H. Ginsenoside Rg1 attenuates okadaic acid induced spatial memory impairment by the GSK3beta/tau signaling pathway and the Abeta formation prevention in rats. Eur J Pharmacol, 710(1–3), 29–38.
137. Cho, K., Yoon, S. Y., Choi, J. E., Kang, H. J., Jang, H. Y., & Kim, D. H. CA-074Me, a cathepsin B inhibitor, decreases APP accumulation and protects primary rat cortical neurons treated with okadaic acid. Neurosci Lett, 548, 222–227.
138. Chen Y, Wang C, Hu M, Pan J, Chen J, Duan P, Zhai T, Ding J, Xu C (2012) Effects of ginkgolide A on okadaic acid-induced tau hyperphosphorylation and the PI3K-Akt signaling pathway in N2a cells. Planta Med 78(12):1337–1341
139. Li, L., Liu, J., Yan, X., Qin, K., Shi, M., Lin, T., Zhu, Y., Kang, T., & Zhao, G. Protective effects of ginsenoside Rd against okadaic acid-induced neurotoxicity in vivo and in vitro. J Ethnopharmacol, 138(1), 135–141.
140. Li, L., Liu, Z., Liu, J., Tai, X., Hu, X., Liu, X., Wu, Z., Zhang, G., Shi, M., & Zhao, G. Ginsenoside Rd attenuates beta-amyloid-induced tau phosphorylation by altering the functional balance of glycogen synthase kinase 3beta and protein phosphatase 2A. Neurobiol Dis, 54, 320–328.
141. Li YK, Chen XC, Zhu YG, Peng XS, Zeng YQ, Sheng J, Huang TW (2005) Ginsenoside Rb1 attenuates okadaic acid-induced Tau protein hyperphosphorylation in rat hippocampal neurons. Sheng Li Xue Bao 57(2):154–160
142. Zimmer ER, Kalinine E, Haas CB, Torrez VR, Souza DO, Muller AP, Portela LV (2010) Pretreatment with memantine prevents Alzheimer-like alterations induced by intrahippocampal okadaic acid administration in rats. Curr Alzheimer Res 9(10):1182–1190
143. Zhang J, Cheng Y, Zhang JT (2007) (2007) [Protective effect of (−) clausenamide against neurotoxicity induced by okadaic acid and beta-amyloid peptide25-35]. Yao Xue Xue Bao 42(9):935–942
144. He J, Yang Y, Xu H, Zhang X, Li XM (2005) Olanzapine attenuates the okadaic acid-induced spatial memory impairment and hippocampal cell death in rats. Neuropsychopharmacology 30(8):1511–1520
145. Suuronen T, Kolehmainen P, Salminen A (2000) Protective effect of l-deprenyl against apoptosis induced by okadaic acid in cultured neuronal cells. Biochem Pharmacol 59(12):1589–1595